The 11th BIOCHINA 2026 Enmore Biopharmaceutical Industry Exhibition will be held from March 12–14 at the Suzhou International Expo Center. Featuring four core components—Exhibition, Conference, Meetings, and Activities—it provides a high-level platform for communication and collaboration across the entire industry chain. The event will welcome over 30,000 attendees from 40+ countries and regions, 850+ speakers, 250+ specialized forums, 3,000+ arranged meetings, and 400+ exhibitors.
DIMA BIOTECH will be showcasing at BIOCHINA 2026 Enmore Biopharmaceutical Industry Conference. We look forward to welcoming you at our booth (F3B13)!
About Us
DIMA BIOTECH. is an innovative biotechnological company providing products and services for biopharmaceutical enterprises. Unlike traditional CROs, DIMA offers functionally validated ready-to-use lead antibody molecules, currently covering over 500 druggable targets and 5,000 ready-to-use antibodies derived from mouse, llama, and rabbit, with antibody sequences available for global licensing. Leveraging the DiMPro™ membrane protein platform, single B-cell antibody discovery, DiLibrary™ antibody engineering, and DiAssay™ functional validation system, DIMA is dedicated to accelerating the preclinical development of antibody therapeutics.
On-site Highlights
-
Full-length Multi-Transmembrane Proteins in Nanodiscs
Membrane protein expression and conformational stability have long been critical technical challenges in antibody discovery. Leveraging the DiPro™ Nanodisc platform, DIMA Biotechnology has successfully established a stable expression system for full-length multi-transmembrane proteins and developed over 700 Nanodisc membrane protein products, with more than 300 available off-the-shelf. Several products have been successfully applied to challenging and high-value targets such as GPCRs and ion channels. Nanodiscs broadly support ELISA, SPR, BLI, immunization, phage display, cell-based assays, Cryo-EM, and small molecule screening.
- ELISA
- SPR
- Phage display screening
- Immunization (Synthetic Nanodisc)
- BLI
- Cell-based assays (PeptiNanodisc)
- Cryo-EM
- Small molecule screening
-
GPCR Flow Antibodies – Limited-Time Offer
To support GPCR membrane protein research and drug development, we are pleased to launch a limited-time discount promotion on GPCR flow cytometry antibodies. This promotion applies to multiple GPCR antibodies validated by flow cytometry, now offered at 30% off for a limited period. All participating products have been confirmed for cell-surface binding and can be used for native conformation recognition, low-abundance target detection, and functional studies. They cover popular targets across immunology, metabolism, neuroscience, and oncology, providing researchers with reliable experimental tools at a more cost-effective price.
DIMA Biotechnology warmly invites you to BIOCHINA 2026 to experience our leading Nanodisc technology firsthand and explore cutting-edge solutions for therapeutic antibody development!
